Surface Marker Allows New Diagnostic Approaches for Sarcoidosis
By LabMedica International staff writers Posted on 08 Nov 2015 |
Image: The Q-Prep/ImmunoPrep lysing system workstation (Photo courtesy of Beckman Coulter).
A new strategy has been developed to determine monocyte subsets involved in diseases that could help facilitate the diagnosis of sarcoidosis and may improve respective patient management.
Monocytes are white blood cells that are crucial to human immune defense and are precursor cells of macrophages and dendritic cells that circulate in the blood until they invade their respective target tissue where they defend the body against exogenous structures.
Scientists at Helmholtz-Zentrum (Munich, Germany) and their colleagues analyzed blood samples of patients suffering from sarcoidosis. This disease, which often leads to damage of the patients' lungs, is caused by a strong immune reaction and a concomitant formation of nodules in the tissue. The underlying mechanisms are still unclear but scientists are convinced that monocytes play a critical role.
The investigators mixed blood with directly conjugated monoclonal antibodies for 20 minutes on ice in the dark. Samples were lysed in a Q-prep workstation (Beckman Coulter, Brea CA, USA) including 0.1% formaldehyde fixation. Equal volumes of counting beads were added and samples were run on a FACSCalibur (Becton-Dickinson; Franklin Lakes, NJ, USA) for 4-color-analysis. A total of 5,000 classical monocytes were acquired per sample.
The team showed that the cell surface marker 6-sulfo LacNAc (slan) can define slan-positive CD14+CD16++ non-classical monocytes and slan-negative CD14++CD16+ intermediate monocytes. Gene expression profiling confirms that slan-negative intermediate monocytes show highest expression levels of major histocompatibility complex (MHC) class II genes, while a differential ubiquitin signature is a novel feature of the slan approach. Using the slan approach they showed that slan-negative intermediate monocytes are increased in sarcoidosis and slan-positive non-classical monocytes are depleted in hereditary diffuse leukoencephalopathy with spheroids (HDLS). The study was published on October 6, 2015, in the journal Blood.
Related Links:
Helmholtz-Zentrum
Beckman Coulter
Becton-Dickinson
Monocytes are white blood cells that are crucial to human immune defense and are precursor cells of macrophages and dendritic cells that circulate in the blood until they invade their respective target tissue where they defend the body against exogenous structures.
Scientists at Helmholtz-Zentrum (Munich, Germany) and their colleagues analyzed blood samples of patients suffering from sarcoidosis. This disease, which often leads to damage of the patients' lungs, is caused by a strong immune reaction and a concomitant formation of nodules in the tissue. The underlying mechanisms are still unclear but scientists are convinced that monocytes play a critical role.
The investigators mixed blood with directly conjugated monoclonal antibodies for 20 minutes on ice in the dark. Samples were lysed in a Q-prep workstation (Beckman Coulter, Brea CA, USA) including 0.1% formaldehyde fixation. Equal volumes of counting beads were added and samples were run on a FACSCalibur (Becton-Dickinson; Franklin Lakes, NJ, USA) for 4-color-analysis. A total of 5,000 classical monocytes were acquired per sample.
The team showed that the cell surface marker 6-sulfo LacNAc (slan) can define slan-positive CD14+CD16++ non-classical monocytes and slan-negative CD14++CD16+ intermediate monocytes. Gene expression profiling confirms that slan-negative intermediate monocytes show highest expression levels of major histocompatibility complex (MHC) class II genes, while a differential ubiquitin signature is a novel feature of the slan approach. Using the slan approach they showed that slan-negative intermediate monocytes are increased in sarcoidosis and slan-positive non-classical monocytes are depleted in hereditary diffuse leukoencephalopathy with spheroids (HDLS). The study was published on October 6, 2015, in the journal Blood.
Related Links:
Helmholtz-Zentrum
Beckman Coulter
Becton-Dickinson
Latest Hematology News
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
- First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
- POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
- First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
- Handheld White Blood Cell Tracker to Enable Rapid Testing For Infections
- Smart Palm-size Optofluidic Hematology Analyzer Enables POCT of Patients’ Blood Cells
- Automated Hematology Platform Offers High Throughput Analytical Performance
- New Tool Analyzes Blood Platelets Faster, Easily and Accurately
- First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC
- Bleeding Risk Diagnostic Test to Reduce Preventable Complications in Hospitals
- True POC Hematology Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Blood Test Could Predict Outcomes in Emergency Department and Hospital Admissions
- Novel Technology Diagnoses Immunothrombosis Using Breath Gas Analysis
- Advanced Hematology System Allows Labs to Process Up To 119 Complete Blood Count Results per Hour
- Unique AI-Based Approach Automates Clinical Analysis of Blood Data